HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Akar Selected Research

Plasminogen Activator Inhibitor 1

10/2006Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
5/2006Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Akar Research Topics

Disease

7Thrombosis (Thrombus)
01/2002 - 02/2000
6Neoplasms (Cancer)
03/2010 - 06/2005
5Venous Thrombosis (Deep-Vein Thrombosis)
03/2010 - 02/2000
3Venous Thromboembolism
01/2008 - 02/2000
3Cerebral Infarction
04/2001 - 05/2000
2Cardiovascular Diseases (Cardiovascular Disease)
05/2006 - 04/2001
2Deafness (Deaf Mutism)
03/2003 - 05/2001
2Amyloidosis
09/2001 - 10/2000
2Stroke (Strokes)
04/2001 - 04/2001
2Ischemic Stroke
04/2001 - 08/2000
2Iron-Deficiency Anemia (Anemia, Iron Deficiency)
04/2001 - 02/2001
2Thromboangiitis Obliterans (Buerger's Disease)
11/2000 - 05/2000
1Leukemia
01/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1Sarcoma (Soft Tissue Sarcoma)
01/2018
1Androgen-Insensitivity Syndrome (Testicular Feminization)
11/2010
1Iron Deficiencies
12/2008
1Breast Neoplasms (Breast Cancer)
10/2006
1Neoplasm Metastasis (Metastasis)
10/2006
1von Willebrand Diseases (von Willebrand's Disease)
07/2006
1Hemophilia A (Haemophilia)
07/2006
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2006
1Obesity
05/2006
1Insulin Resistance
05/2006
1Type 2 Diabetes Mellitus (MODY)
05/2006
1Urinary Tract Infections (Urinary Tract Infection)
02/2006
1Pyelonephritis
02/2006
1Sensorineural Hearing Loss
01/2005
1Pathologic Dilatation (Ectasia)
02/2003
1Hearing Loss (Hearing Impairment)
01/2003
1Pulmonary Embolism
04/2002
1Hydrocephalus (Hydrocephaly)
01/2002
1Thrombophilia
01/2002
1Sepsis (Septicemia)
01/2002
1Tetralogy of Fallot (Fallot Tetralogy)
01/2002
1Cardiomyopathies (Cardiomyopathy)
01/2002
1Homocystinuria
01/2002
1Proteinuria
09/2001
1Hyperpigmentation
09/2001
1Nephrotic Syndrome (Syndrome, Nephrotic)
09/2001
1Hereditary Spherocytosis
06/2001
1Thalassemia
06/2001
1Hemolytic Anemia
06/2001
1Hyperhomocysteinemia
04/2001
1Myocardial Infarction
04/2001
1Budd-Chiari Syndrome (Budd Chiari Syndrome)
03/2001
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2000
1Intracranial Embolism
09/2000
1Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
08/2000
1Infarction (Infarctions)
06/2000
1Protein C Deficiency
06/2000
1Activated Protein C Resistance (APC Resistance)
05/2000
1Spinal Dysraphism (Spina Bifida)
03/2000

Drug/Important Bio-Agent (IBA)

12Factor V (Coagulation Factor V)IBA
01/2008 - 02/2000
5Plasminogen Activators (Plasminogen Activator)IBA
01/2007 - 02/2000
4Factor VIII (Coagulation Factor VIII)IBA
07/2006 - 12/2000
4factor V LeidenIBA
06/2005 - 05/2000
4Prothrombin (Factor II)IBA
01/2002 - 05/2000
3A-factor (Streptomyces)IBA
01/2008 - 11/2000
3Connexin 26IBA
01/2005 - 05/2001
3HomocysteineIBA
04/2001 - 03/2000
3Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
04/2001 - 02/2000
2Plasminogen Activator Inhibitor 1IBA
10/2006 - 05/2006
2ColchicineFDA LinkGeneric
09/2001 - 10/2000
1NucleophosminIBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018
1Testosterone (Sustanon)FDA Link
11/2010
1Factor VII (Proconvertin)IBA
03/2010
1HepcidinsIBA
12/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2006
1aerobactinIBA
02/2006
1Virulence Factors (Pathogenicity Factors)IBA
02/2006
1Fibrinogen (Factor I)FDA Link
02/2006
1Mitochondrial DNA (mtDNA)IBA
03/2003
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2003
1Serum AlbuminIBA
09/2001
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2001
1Codon (Codons)IBA
06/2001
1Integrin alpha2IBA
04/2001
1methionine synthase reductaseIBA
04/2001
1Collagen ReceptorsIBA
04/2001
1Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
04/2001
1EnzymesIBA
04/2001
1ZincIBA
04/2001
1AntioxidantsIBA
02/2001
1Troleandomycin (TAO)FDA Link
11/2000
1gamma-glutamylaspartic acidIBA
08/2000
1Endothelin-1 (Endothelin 1)IBA
08/2000
1von Willebrand FactorIBA
08/2000

Therapy/Procedure

2Therapeutics
09/2001 - 10/2000
1Indwelling Catheters (Indwelling Catheter)
01/2002
1Drug Therapy (Chemotherapy)
01/2002